33240-19-6

Basic information

• Product Name: ethyl 3-[(2-methylphenyl)amino]but-2-enoate
• Synonyms: ethyl 3-[(2-methylphenyl)amino]but-2-enoate
• CAS NO: 33240-19-6
• Molecular Weight: 219.283
• Mol File: 33240-19-6.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: ethyl 3-[(2-methylphenyl)amino]but-2-enoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-[(2-methylphenyl)amino]but-2-enoate(33240-19-6)
• EPA Substance Registry System: ethyl 3-[(2-methylphenyl)amino]but-2-enoate(33240-19-6)

Safety Data

• Hazardous Substances Data: 33240-19-6(Hazardous Substances Data)

Upstream product

• 141-97-9 ethyl acetoacetate 
• 95-53-4 o-toluidine 

Downstream Products

• 52481-91-1 4-hydroxy-2,8-dimethylquinoline 
• 102949-47-3 5-(3,5-dinitro-benzoyloxy)-2-methyl-1-o-tolyl-indole-3-carboxylic acid ethyl ester 
• 121233-54-3 5-(2-methoxy-benzoyloxy)-2-methyl-1-o-tolyl-indole-3-carboxylic acid ethyl ester 
• 102876-88-0 5-benzoyloxy-2-methyl-1-o-tolyl-indole-3-carboxylic acid ethyl ester 
• 205997-78-0 4-ethoxy-2,8-dimethyl-quinoline 
• 51736-02-8 2-[1-(2-methyl-anilino)-ethylidene]-N-phenyl-3-thio-malonamic acid ethyl ester 
• 5165-44-6 5-hydroxy-2-methyl-1-o-tolyl-indole-3-carboxylic acid ethyl ester 
• 15644-80-1 2,8-dimethyl-quinolin-4-ol 
• 49612-06-8 4-hydrazino-2,8-dimethylquinoline 
• 32314-39-9 4-chloro-2,8-dimethylquinoline 
• 55213-17-7 (Z)-2-(4-Methoxy-phenylthiocarbamoyl)-3-o-tolylamino-but-2-enoic acid ethyl ester 

Relevant articles and documents

Synthesis of 3 H -Pyrrolo[2,3- c ]quinoline by Sequential i 2 -Promoted Cyclization/Staudinger/Aza-Wittig/Dehydroaromatization Reaction

A facile synthetic approach to access of 3 H -pyrrolo[2,3- c ]quinoline derivatives has been achieved by a sequential I 2 -promoted cyclization/Staudinger/aza-Wittig/dehydroaromatization reaction. The targeted products were received in moderate

HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS

The present invention is directed to heterocyclic compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Three naphthalenedisulfonate polymers with imidazole-containing ligands: Synthesis, structure and heterogeneously catalytic performance in reactions of enamination of β-dicarbonyl compounds

Three new naphthalenedisulfonate polymers, [Cd(2,6-nds)(bib)]n (1), [Cd(1,5-nds)(bib)]n (2), and [Cu(2,6-nds)0.5(tpim)]n (3), have been successfully synthesized by hydrothermal reactions of corresponding metal salts with naphthalenedisulfonate (nds) and imidazole-containing ligands 1,4-bis(imidazol-1-ylmethyl)benzene (bib) and 2,4,5-tri(4-pyridyl)-imidazole (tpim). The structures of these polymers were determined by single crystal X-ray diffraction analysis. Polymers 1 and 2 crystallize in the same space group and have similar cell parameters, and thus show same three-dimensional (3D) framework architecture. Complex 3 has the same 2D layer structure. The photoluminescent properties of the complexes 1 and 2 were investigated. Catalytic tests indicate that complex 3 has chemo-and regio-selective catalytic activity towards enamination of β-ketoesters.